X4 Pharmaceuticals, Inc. (XFOR)
4.28
+0.11
(+2.64%)
USD |
NASDAQ |
Mar 20, 16:00
4.265
-0.02
(-0.35%)
After-Hours: 20:00
X4 Pharmaceuticals Research and Development Expense (Quarterly) : 18.50M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Immuneering Corp. | 9.194M |
| Tango Therapeutics, Inc. | 31.62M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |